Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG:2196)
Hong Kong
· Delayed Price · Currency is HKD 14.80
+0.16 (1.09%)
Apr 24, 2025, 4:08 PM HKT
Shanghai Fosun Pharmaceutical (Group) Employees
Shanghai Fosun Pharmaceutical (Group) had 40,557 employees as of December 31, 2024. The number of employees increased by 187 or 0.46% compared to the previous year.
Employees
40,557
Change (1Y)
187
Growth (1Y)
0.46%
Revenue / Employee
1.08M HKD
Profits / Employee
72.68K HKD
Market Cap
62.27B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| BeiGene | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| JD Health International | 3,564 |
| WuXi Biologics | 12,575 |
| Innovent Biologics | 5,659 |
| Akeso | 3,035 |
| Alibaba Health Information Technology | 1,435 |
| CSPC Pharmaceutical Group | 21,400 |
Shanghai Fosun Pharmaceutical (Group) News
- 4 weeks ago - Shanghai Fosun Pharmaceutical reports FY results - Seeking Alpha
- 1 year ago - Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse - Reuters
- 2 years ago - Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech - Forbes
- 3 years ago - Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal - Seeking Alpha
- 4 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 4 years ago - Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse - Seeking Alpha
- 4 years ago - Week In Review: CANbridge Licenses LogicBio's Adeno-Associated Virus For Gene Therapies In $591 Million Deal - Seeking Alpha
- 4 years ago - Fosun Pharma shares tumble more than 5% as Hong Kong suspends BioNTech Covid vaccinations - CNBC